• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Cell Therapy
    • Cell Therapy at the Limits 2021
  • Oncology
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
      • UCL Frontiers of Oncology 2019
        • Haematology
        • Melanoma
        • Urology
        • Women’s Health
        • Lung Cancer
        • Gastrointestinal Oncology
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2021
    • Multiple Sclerosis Nurses at the Limits 2021
    • Previous events
      • Multiple Sclerosis at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2019
      • MSATL 2018: Introduction
      • MSATL 2017: Introduction
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Supporters
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis at the Limits 2018
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series
      • Horizon GP Programme 2019
      • Hatter Horizon Series 2019
      • Hatter Horizon Series 2018
      • Hatter Horizon Series 2017
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017

CDNATL 2017: Programme

cdnatl-new-logo-ai

Saturday 8th - Sunday 9th April 2017
The University of Cape Town, Cape Town, South Africa

Chairpersons & Scientific Committee:
Professor Derek Yellon, Professor Sir John Cunningham, Professor Brian Rayner, Professor Mpiko Ntsekhe,
Dr Peter Libby, Dr Marc Pfeffer, Dr Richard Horton, Professor Lionel Opie, & Professor Karen Sliwa

Please click here for a printable PDF version of this programme.

Please note that timings are provisional and subject to change.
Speaker Conflict of Interest forms are here
Confirmation of accreditation is here
Saturday morning

09.00
Opening Remarks & Welcome
Professor Derek Yellon
Professor Bongani Mayosi

09.15
Dr Peter Libby
The Lancet Lecture:
Novel concepts of the pathogenesis of the acute coronary syndromes.
Dr Peter Libby
Harvard Medical School, Boston, USA


10.00
Dr Alex Lyon
Cardio-Oncology – preventing the cancer patient of today being the heart failure patient of tomorrow!
Dr Daniel Lenihan
Vanderbilt University Medical Center, Nashville, USA


10.40
Break


11.10
Professor Natan Bornstein
What is the connection between the heart and the brain?
Professor Natan Bornstein
Tel Aviv Medical Centre, Israel


11.50
Professor Bernard Gersh
PCI vs CABG for multi-vessel and left main coronary disease – do we have the evidence?
Professor Bernard Gersh
Mayo Clinic College of Medicine, Rochester, USA


12.30
Lunch


Saturday afternoon

13.30
Professor C Noel Bairey Merz
The Hatter Award Lecture:
Is it time to look at microvascular angina? Are these the new limits?
Dr C Noel Bairey Merz
Cedars-Sinai Heart Institute, California, USA


14.10
Professor John Wilding
SGLT2 inhibition – a novel strategy to improve type 2 diabetes, cardiovascular & renal outcome
Professor John Wilding
University Hospital, Liverpool, UK


14.50
Professor Steven Weisbord
Trials and tribulations in AKI. Do we know where we are going?
Dr Steven Weisbord
VA Pittsburgh Healthcare System, USA


15.30
Break


16.00
Professor Gerd Heusch
The preconditioning phenomenon – lost in translation?
Professor Gerd Heusch
University of Essen, Germany


16.40
Professor David Wheeler
The NIHR-UCLH Biomedical Research Centre Lecture:
Diabetes & the kidney: BP control-how low can you go?
Professor David Wheeler
University College London, UK


17:20
Close


Saturday evening
19:00
Dame Nicola Brewer
Pre-dinner talk:
Are there limits to global engagement?
Dame Nicola Brewer
UK High Commission to South Africa (2009 – 2013) Vice Provost – International, University College London, UK


Sunday morning

09:00
Professor Naomi Levitt
The global burden of diabetes.
Professor Naomi Levitt
University of Cape Town, South Africa


09:40
Dr Liesl Zuhlke
The SA Heart & British Cardiovascular Society Lecture:
The prevention, management and control of rheumatic heart disease: are we at the limits?
Professor Liesl Zühlke
University of Cape Town, South Africa


10:20
Break


10:50
Professor Chris Winearls
eGFR & CKD Staging. Better understanding or a struggle with the law of unintended consequences?
Dr Chris Winearls
University of Oxford, UK


11:30
Professor Allison Goldfine
GLP-1 analogues & DPPIV Inhibitors – are there new limits for beneficial cardiovascular outcome in type 2 diabetes?
Professor Allison Goldfine
Joslin Diabetes Centre, Boston, USA


12:10
Lunch


Sunday afternoon

13:10
Professor Kausik Ray
PCSK9 inhibition – have we reached the limits of lipid lowering and outcome?
Professor Kausik Ray
Imperial College, London, UK


13:50
Professor Iain MacDougall v Dr Marc Pfeffer
Debate: Strategies for optimising haemoglobin in CKD (both pre and post dialysis) & CV Disease. What level and how to get there?
For: Professor Iain Macdougall
Kings College, London, UK

 

Against: Dr Marc Pfeffer
Harvard University, Boston, USA


14:50
Summary


15:00
Close


The program and its educational value are endorsed by The British Cardiovascular Society, The South African Heart Association, The UK Renal Association, The NIHR-UCLH Biomedical Research Centre & The Lancet

Cardiology, Diabetes and Nephrology at the Limits is supported by educational grants from Government, Pharmaceutical Industry, and other Medical Associations.
A list of 2017 supporters is at https://www.atthelimits.org/cardiology-diabetes-nephrology/cdnatl-2017/supporters/

Cardiology, Diabetes & Nephrology at the Limits Canada
Wednesday, 3 & Thursday, 4 March 2021, Virtual Meeting

Cardiology, Diabetes & Nephrology at the Limits 2021
Monday, 12 & Tuesday, 13 April 2021, Virtual Meeting

The 18th Malvern Diabetic Foot Conference
Wednesday, 12 – Friday, 14 May 2021, Malvern, UK

Multiple Sclerosis Nurses
at the Limits

Friday, 10 & Saturday, 11 September 2021, London, UK

Multiple Sclerosis at the Limits
Monday, 13 & Tuesday, 14 September 2021, London, UK

Hatter Horizon GP Meeting
Monday, 1 November 2021
London, UK

Cell Therapy at the Limits 2021
Monday, 8 & Tuesday, 9 November 2021, London, UK

Hatter Horizon Series
Monday, 22 November 2021, London, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 10 - Saturday, 11 December 2021, São Paulo, Brazil

Policy links

  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2021 At the Limits Ltd.
This site uses cookies More info